Rachael Moliver

FDA investigator

Appears on 13 documents from 2016 to 2020, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).

13
Documents on file
6.1
Observations per 483
2016
First seen
2020
Most recent

What they cite most

From 79 observations

Activity by year

2016: 1, 2017: 4, 2018: 4, 2019: 3, 2020: 1

Where

New York 10 · New Jersey 1 · North Carolina 1 · Vermont 1

Is Rachael Moliver coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Tekweld Solutions IncJan 17, 2020 · Hauppauge, New York
483 Life Science Pharmacy Inc.Nov 20, 2019 · Harriman, New York
483 Maimonides Medical CenterJul 29, 2019 · Brooklyn, New York
483 Metro Drugs 3rd Avenue CorpApr 5, 2019 · New York, New York
483 Town and Country Compounding and Consultation Services, LLCDec 11, 2018 · Ridgewood, New Jersey
483 Kings Park Slope IncSep 14, 2018 · Brooklyn, New York
483 Pine Pharmaceuticals, LLCApr 26, 2018 · Tonawanda, New York

About this profile

What does Rachael Moliver inspect?

Rachael Moliver appears on 13 documents on file covering 13 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and FDCA 501(a)(2)(A).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rachael Moliver is dated Jan 17, 2020.